Dengue virus infection in Africa

Emerging Infectious Diseases

Volumn 17, Issue 8, 2011, Pages 1349-1354

  Amarasinghe, Ananda ^a   Kuritsky, Joel N ^a   William Letson, G ^a   Margolis, Harold S ^b  

^a International Vaccine Institute   (South Korea)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

NEUTRALIZING ANTIBODY; VIRUS ANTIBODY;

AEDES AEGYPTI; AEDES ALBOPICTUS; AFRICA; ARTICLE; DENGUE; DENGUE VIRUS 1; DENGUE VIRUS 2; DIAGNOSTIC ERROR; DIFFERENTIAL DIAGNOSIS; ENDEMIC DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPIDEMIC; FEVER; HOST SUSCEPTIBILITY; HUMAN; INCIDENCE; MALARIA; PREVALENCE; TRAVEL; VIRUS INFECTIVITY; VIRUS TRANSMISSION;

AEDES; AFRICA; ANIMALS; DENGUE; DENGUE VIRUS; DISEASE OUTBREAKS; HUMANS; INCIDENCE; PREVALENCE;

EID: 79960854803     PISSN: 10806040     EISSN: 10806059     Source Type: Journal    
DOI: 10.3201/eid1708.101515     Document Type: Article

References (40)

1. Gubler DJ, Clark GG. Dengue/dengue hemorrhagic fever: the emergence of a global health problem. Emerg Infect Dis. 1995;1:55-7. doi:10.3201/eid0102.950204
2. Gubler DJ. The changing epidemiology of yellow fever and dengue, 1900 to 2003: full circle? Comp Immunol Microbiol Infect Dis. 2004;27:319-30. doi:10.1016/j.cimid.2004.03.013
3. Halstead SB. Dengue: overview and history. In: Halstead SB, editor. Dengue. London: Imperial College Press; 2008. p. 1-28.
4. United Nations. Demographic year book, 1950-2007. United Nation Statistics Division. Demographic and Social Statistics [cited 2009 Dec 23]. http://unstats.un.org/unsd/demographic/products/dyb/dyb2.htm
5. World Health Organization. Dengue: guidelines for diagnosis, treatment, prevention and control. Geneva: The Organization; 2009.
6. Dengue/DHF update. 2009 Nov 23 [cited 2011 Apr 12] http://www.promedmail.org,archiveno.20091123.4016.
7. Cornet M. Dengue in Africa. Epidemiology of dengue and dengue hemorrhagic fever. Monograph on dengue/dengue hemorrhagic fever. Geneva: World Health Organization; 1993. p. 39-47.
8. Sang RC. Dengue in Africa. In: Report of the scientific working group meeting on dengue. Geneva, October 1-5, 2006. WHO Special Programme for Research and Training in Tropical Diseases; 2007. p. 50-2 [cited 2011 Apr 13]. http://whqlibdoc.who.int/hq/2007/TDR_SWG_08_eng.pdf
9. World Health Organization. Dengue in Africa: emergence of DENV- 3, Côte d'Ivoire, 2008. Wkly Epidemiol Rec. 2009;84:85-8.
10. Carey DE, Causey OR, Reddy S, Cooke AR. Dengue viruses from febrile patients in Nigeria, 1964-1968. Lancet. 1971;1:105-6. doi:10.1016/S0140-6736(71)90840-3
11. Freedman DO, Weld LH, Kozarsky PE, Fisk T, Robins R, Sonnenburg FV, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med. 2006;354:119-30. doi:10.1056/NEJMoa051331
12. Wichmann O, Muhlberger N, Jelinek T. Dengue: the underestimated risk in travelers. Dengue Bulletin. 2003;27:126-37.
13. Jelinek T. Trends in the epidemiology of dengue fever and their relevance for importation to Europe. Euro Surveill. 2009;14:pii:19250.
14. Jansen A, Frank C, Koch J, Strak K. Surveillance of vector-borne disease in Germany: trends and challenges in the view of disease emergence and climate change. Parasitol Res. 2008;103(Suppl 1):S11-7. doi:10.1007/s00436-008-1049-6
15. Wilson ME, Weld LH, Boggild A, Keystone JS, Kain KC, Sonnenburg FV, et al. Fever in returned travelers: results from the Geosentinel Surveillance Network. Clin Infect Dis. 2007;44:1560-8. doi:10.1086/518173
16. Fagbami AH, Monath TP, Fabiyi A. Dengue virus infections in Nigeria: a survey for antibodies in monkeys and humans. Trans R Soc Trop Med Hyg. 1977;71:60-5. doi:10.1016/0035-9203(77)90210-3
17. Collenberg E, Quedraogo T, Ganamé J, Fickenscher H, Kynast-Wolf G, Becher H, et al. Seroprevalence of six different viruses among pregnant women and blood donors in rural and urban Burkina Faso: a comparative analysis. J Med Virol. 2006;78:683-92. doi:10.1002/ jmv.20593
18. Kuniholm MH, Wolfe ND, Huang CY, Mpoudi-Ngole E, Tamoufe U, LeBreton M, et al. Seroprevalence and distribution of Flaviviridae, Togaviridae and Bunyaviridae arboviral infections in rural Cameroonian adults. Am J Trop Med Hyg. 2006;74:1078-83.
19. Amarasinghe A, Beatty ME, Wichmann O, Kuritsky JN, Margolis HS, Letson GW. Comparison of epidemiological field site surveillance of dengue. In: Abstracts of the 5th TEPHINET Southeast Asia and Western Pacific Bi-Regional Scientific Conference, Seoul, South Korea, Nov 2-6, 2009. Training Programs in Epidemiology and Public Health Interventions Network: 2009. Abstract A0130 [cited 2011 May 3]. http://www.tephinet2009korea.com
20. Amexo M, Tolhurst R, Branish G, Bates I. Malaria misdiagnosis: effects on the poor and vulnerable. Lancet. 2004;364:1896-8. doi:10.1016/S0140-6736(04)17446-1
21. Ndyomugyenyi R, Magnussen P, Clarke S. Diagnosis and treatment of malaria in peripheral health facilities in Uganda: findings from an area of low transmission in south-western Uganda. Malar J. 2007;6:39. doi:10.1186/1475-2875-6-39
22. Dechant EJ, Rigau-Pérez G; The Puerto Rico Association of Epidemiologists. Hospitalizations for suspected dengue in Puerto Rico, 1991-1995: estimation by capture-recapture methods. Am J Trop Med Hyg. 1999;61:574-8.
23. Wichmann O, Yoon IK, Vong S, Limkittikul K, Gibbons RV, Buchy P, et al. Dengue in Thailand and Cambodia: an assessment of the degree of underestimated disease burden based on reported cases. In: Abstracts of the International Meeting on Emerging Diseases and Surveillance; Vienna, Austria; Feb 13-16, 2009. Brookline (MA): The International Society for Infectious Diseases; 2009. Abstract 18.038.
24. Hyams KC, Oldfield EC, Scott RM, Bourgeois AL, Gardner H, Pazzaglia G, et al. Evaluation of febrile patients in Port Sudan, Sudan: isolation of dengue virus. Am J Trop Med Hyg. 1986;35:860-5.
25. Monath TP. Dengue: the risk to developed and developing countries. Proc Natl Acad Sci U S A. 1994;91:2395-400. doi:10.1073/ pnas.91.7.2395
26. Appawu M, Dadzie S, Abdul H, Asmah H, Boakye D, Wilson M, et al. Surveillance of viral haemorrhagic fevers in Ghana: entomological assessment of the risk transmission in the northern regions. Ghana Med J. 2006;40:137-41.
27. Gubler DJ, Nalim S, Tan R, Saipan H, Sulianti Saroso J. Variation in susceptibility to oral infection with dengue viruses among geographic strains of Aedes aegypti. Am J Trop Med Hyg. 1979;28:1045-52.
28. Gubler DJ, Rosen L. Variation among geographic strains of Aedes albopictus in susceptibility to infection with dengue viruses. Am J Trop Med Hyg. 1976;25:318-25.
29. Diallo M, Ba Y, Faye O, Soumare ML, Dia I, Sall AA. Vector competence of Aedes aegypti populations from Senegal for sylvatic and epidemic dengue 2 virus isolated in west Africa. Trans R Soc Trop Med Hyg. 2008;102:493-8. doi:10.1016/j.trstmh.2008.02.010
30. Armstrong PM, Rico-Hesse R. Efficiency of dengue serotype 2 virus strains to infect and disseminate in Aedes aegypti. Am J Trop Med Hyg. 2003;68:539-44.
31. Monath TP. The absence of yellow fever in Asia hypotheses: a case for concern? Virus Information Exchange Newsletter. 1989;6:106-7.
32. Ratsitorahina M, Harisoa J, Ratovonjato J, Biacabe S, Reynes JM, Zeller H, et al. Outbreak of dengue and chikungunya fevers, Toamasina, Madagascar, 2006. Emerg Infect Dis. 2008;14:1135-7. doi:10.3201/eid1407.071521
33. Metselaar D, Grainger CR, Oei KG, Reynolds DG, Pudney M, Leake CJ, et al. An outbreak of type 2 dengue fever in the Seychelles, probably transmitted by Aedes albopictus (Skuse). Bull World Health Organ. 1980;58:937-43.
34. Lambrechts L, Scott TW, Gubler DJ. Consequences of the expanding global distribution of Aedes albopictus for dengue virus transmission. PLoS Negl Trop Dis. 2010;4:e646. doi:10.1371/journal. pntd.0000646.
35. Vasilakis N, Holmes EC, Fokam EB, Faye O, Diallo M, Sall AA, et al. Evolutionary process among sylvatic dengue type 2 viruses. J Virol. 2007;81:9591-5. doi:10.1128/JVI.02776-06
36. Halstead SB, Streit TG, Lafontant JG, Putvatana R, Russell K, Sun W, et al. Haiti: absence of dengue hemorrhagic fever despite hyperendemic dengue virus transmission. Am J Trop Med Hyg. 2001;65:180-3.
37. Kouri GP, Guzmán MG, Bravo JR, Triana C. Dengue haemorrhagic fever/dengue shock syndrome: lessons from the Cuban epidemic, 1981. Bull World Health Organ. 1989;67:375-80.
38. de la C Sierra B, Kouri G, Guzmán MG. Race: a risk factor for dengue hemorrhagic fever. Arch Virol. 2007;152:533-42. doi:10.1007/ s00705-006-0869-x
39. LeDuc JW, Esteves K, Gratz NG. Dengue and dengue haemorrhagic fever. In: Murray CJ, Lopez AD, Mathers CD, editors. The global epidemiology of infectious diseases. Vol. IV. Global burden of disease and injury series. Geneva: World Health Organization; 2004. p. 219-42.
40. Webster DP, Farrar J, Rowland-Jones S. Progress toward a dengue vaccine. Lancet Infect Dis. 2009;9:678-87. doi:10.1016/S1473- 3099(09)70254-3